SYN-Tech Chem & Pharm Co Ltd (1777) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.099x

Based on the latest financial reports, SYN-Tech Chem & Pharm Co Ltd (1777) has a cash flow conversion efficiency ratio of 0.099x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$256.05 Million ≈ $8.07 Million USD) by net assets (NT$2.59 Billion ≈ $81.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SYN-Tech Chem & Pharm Co Ltd stock valuation for the company's overall valuation and market capitalisation.

SYN-Tech Chem & Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how SYN-Tech Chem & Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

SYN-Tech Chem & Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SYN-Tech Chem & Pharm Co Ltd ranked by their cash flow conversion efficiency. Explore 1777 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
SinoMedia Holding Limited F:SJY	0.012x
Deleum Bhd KLSE:5132	0.116x
Ryvu Therapeutics SA WAR:RVU	-0.553x
Cellectis PA:ALCLS	-0.255x
Social Commerce Partners Corporation Class A Ordinary Shares NASDAQ:SCPQ	-0.001x
LI Ming Development Construction Co Ltd TWO:6212	-0.035x
Fabryki Mebli Forte S.A. WAR:FTE	0.029x
New Asia Construction & Development Corp TW:2516	-0.226x

Annual Cash Flow Conversion Efficiency for SYN-Tech Chem & Pharm Co Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of SYN-Tech Chem & Pharm Co Ltd from 2015 to 2025. View 1777 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$2.59 Billion ≈ $81.61 Million	NT$559.49 Million ≈ $17.63 Million	0.216x	-11.18%
2024-12-31	NT$2.56 Billion ≈ $80.66 Million	NT$622.61 Million ≈ $19.62 Million	0.243x	+114.86%
2023-12-31	NT$2.32 Billion ≈ $73.01 Million	NT$262.29 Million ≈ $8.26 Million	0.113x	-43.27%
2022-12-31	NT$2.20 Billion ≈ $69.29 Million	NT$438.81 Million ≈ $13.83 Million	0.200x	+152.09%
2021-12-31	NT$1.98 Billion ≈ $62.49 Million	NT$156.98 Million ≈ $4.95 Million	0.079x	-69.24%
2020-12-31	NT$1.24 Billion ≈ $39.08 Million	NT$319.21 Million ≈ $10.06 Million	0.257x	+30.86%
2019-12-31	NT$1.16 Billion ≈ $36.55 Million	NT$228.12 Million ≈ $7.19 Million	0.197x	+14.63%
2018-12-31	NT$1.10 Billion ≈ $34.62 Million	NT$188.49 Million ≈ $5.94 Million	0.172x	+298.39%
2017-12-31	NT$996.24 Million ≈ $31.39 Million	NT$42.89 Million ≈ $1.35 Million	0.043x	-81.19%
2016-12-31	NT$1.03 Billion ≈ $32.37 Million	NT$235.26 Million ≈ $7.41 Million	0.229x	+48.07%
2015-12-31	NT$969.06 Million ≈ $30.53 Million	NT$149.84 Million ≈ $4.72 Million	0.155x	--

About SYN-Tech Chem & Pharm Co Ltd

TWO:1777 Taiwan Biotechnology

Market Cap

$103.82 Million

NT$3.30 Billion TWD

Market Cap Rank

#19158 Global

#1060 in Taiwan

Share Price

NT$73.90

Change (1 day)

+0.27%

52-Week Range

NT$70.30 - NT$78.80

All Time High

NT$108.00